HC Wainwright Begins Coverage on Omeros (NASDAQ:OMER)
Analysts at HC Wainwright began coverage on shares of Omeros (NASDAQ:OMER – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. The brokerage set a “buy” rating and a $9.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s target price indicates a potential upside of 148.62% from the stock’s […]
Analysts at HC Wainwright began coverage on shares of Omeros (NASDAQ:OMER – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. The brokerage set a “buy” rating and a $9.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s target price indicates a potential upside of 148.62% from the stock’s […]
